Keywords: supplemental, nda, foscavir, astra, filed, new, drug

SUPPLEMENTAL NDA FOR FOSCAVIR

Article | 07 December 1992

Print This

- Astra has filed a supplemental New Drug Application for Foscavir (foscarnet) in the USA. The NDA is for Foscavir injection ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in